DPIIT recognised startup Government of India
Startup India
Celecon Pharmaceuticals Private Limited
Celecon Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
About Celecon Pharmaceuticals Private Limited
Data last updated:
Celecon Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC327163. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Kumar Singh and Dhananjay Kumar Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 302, Plot No 14 Saini Enclave, Delhi, India – 110092.
Celecon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0006891). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC327163
Registration Number 327163
Incorporation Date 14 December 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0006891
Recognitions & Rankings of Celecon Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-02-0006891
Contact details
Celecon Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No 302, Plot No 14 Saini Enclave, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Celecon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Celecon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Celecon Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Celecon Pharmaceuticals Private Limited, buy the company report.
Financials of Celecon Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Celecon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Celecon Pharmaceuticals Private Limited
Celecon Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Singh | Director | 23 Nov 2024 | 1 Years 11 Months | Current |
| Dhananjay Kumar Rai | Director | 14 Dec 2017 | 8 Years 11 Months | Current |
Auditor
Celecon Pharmaceuticals Private Limited is audited by KUMAR TIWARI & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR TIWARI & CO | FY 2018 | 024673N |
Shareholding
The shareholding of Celecon Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Celecon Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Celecon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celecon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Celecon Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Celecon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Celecon Pharmaceuticals Private Limited has 7 board changes on record since 2017: 2 appointments and 5 cessations. The latest: Manoj Kumar Singh was appointed as Director on 23 Nov 2024.
AGM
Celecon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Celecon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Manoj Kumar Singh was appointed as Director.
Ceased
Mukesh Kumar Jha ceased to be Director.
Ceased
Ranjeet Kumar Thakur ceased to be Director.
Ceased
Manoj Kumar Singh ceased to be Director.
Ceased
Lakshman Narayan Singh ceased to be Director.
Ceased
Sanjay Kumar Chaubey ceased to be Director.
Appointed
Dhananjay Kumar Rai was appointed as Director.
Incorporation
14 Dec 2017
Celecon Pharmaceuticals Private Limited was registered on 14 Dec 2017 with Roc Delhi I & aged 8 years 11 months as per MCA records.
Frequently asked questions
Celecon Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 December 2017 (9+ years old) and is registered under CIN U74999DL2017PTC327163.
Celecon Pharmaceuticals has 2 current directors:
- Manoj Kumar Singh - Director
- Dhananjay Kumar Rai - Director
The latest financial statements of Celecon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
No. Celecon Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Celecon Pharmaceuticals is U74999DL2017PTC327163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celecon Pharmaceuticals was incorporated on 14 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Manoj Kumar Singh was appointed as Director on 23 Nov 2024. Mukesh Kumar Jha ceased to be Director on 23 Nov 2024. Ranjeet Kumar Thakur ceased to be Director on 14 Apr 2023. Celecon Pharmaceuticals has 7 board changes on record in total.
Yes, Celecon Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Celecon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0006891).
The registered office of Celecon Pharmaceuticals is at Office No 302, Plot No 14 Saini Enclave, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages